EMA Authorised: Vaborem (meropenem trihydrate;vaborbactam) — Menarini International Operations Luxembourg S.A.

View source ↗

Summary

The European Medicines Agency authorised Vaborem, a meropenem trihydrate and vaborbactam combination, for use in several infections. It covers urinary tract inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Pneumonia
• Respiratory Tract Infection
• Urinary Tract Infection
• Ventilator-associated Pneumonia

Drugs mentioned

• Vaborem (meropenem/vaborbactam)

Snippet

Status: Authorised. Therapeutic area: Urinary Tract Infections;Bacteremia;Bacterial Infections;Respiratory Tract Infections;Pneumonia;Pneumonia, Ventilator-Associated. MAH: Menarini International Operations Luxembourg S.A.. Decision date: 12/02/2026